Mangoceuticals Cash Flow Statement (2023-2025) | MGRX

Cash Flow Statement Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Operating Activities
Net Income -2.56M-2.28M-1.80M-2.57M-2.37M-2.39M-2.00M-1.95M-4.84M-5.42M-7.62M
Depreciation and Depletion 0.01M0.01M0.01M0.01M0.01M0.00M252.00255.00250.00252.00255.00
Share-based Compensation 0.06M1.02M0.08M0.36M0.42M0.81M0.46M0.42M1.94M3.18M5.54M
Gains from Investment Securities 1.40M0.09M0.18M2.37M2.37M0.16M0.16M0.16M0.16M2.16M
Non-cash Items 0.71M0.64M0.12M1.90M1.98M0.14M0.14M0.15M0.15M0.65M
Cash from Operations -1.81M-1.78M-1.71M-1.70M-0.99M-1.58M-1.17M-1.13M-2.27M-1.26M-1.24M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) 0.01M0.01M0.01M0.01M0.01M0.00M255.00250.00252.00256.00
Change in Working Capital
Change in Inventory -0.00M-0.00M-0.00M-433.00-806.00
Change in Accured Expenses -0.04M0.05M0.88M-0.30M-0.01M0.13M0.34M0.09M-0.64M
Change in Taxes 0.00M-0.00M0.00M-0.00M893.00-0.01M0.00M
Other Working Capital Changes 0.02M0.02M0.03M-0.13M0.28M0.28M0.03M-0.00M-0.02M-0.02M0.13M
Investing Activities
Capital Expenditures 0.00M
Cash from Investing Activities -0.00M
Financing Activities
Cash from Financing Activities 5.00M0.86M1.20M0.27M1.99M0.75M1.12M2.29M1.28M1.62M
Additional items
Exchange Rate Effect -70.00-0.00M-497.00-0.01M0.01M187.00-45.00
Change in Cash 3.19M-0.92M-1.71M-0.50M-0.72M0.48M-0.42M-0.01M0.01M0.02M0.38M
Free Cash Flow -1.81M-1.78M-1.71M-1.70M-0.99M-1.58M-1.17M-1.13M-2.27M-1.26M-1.24M
Net Cash Flow 3.19M-0.92M-1.71M-0.50M-0.72M0.41M-0.42M-0.01M0.01M0.02M0.38M